Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema
HANGZHOU, China, SHANGHAI and BOSTON, June 1, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that its...
Noah Reports Q1 2026 Earnings: Transformation Momentum Continues, Driven by Scalable AI Breakthroughs and Long-Term Growth Engines
AI integration and disciplined expansion drive operating margin to 37.8% Domestic business refocusing on long-term investments; RMB-denominated private secondary products increased 63.6% year-over-year Global network transitions from license...
OCI Global Receives U.S. Regulatory Approval for the Sale of its Global Methanol Business to Methanex Corporation
AMSTERDAM, June 12, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI), ("OCI", the "Company") today announced that the regulatory review period under the U.S. Hart-Scott-Rodino Antitrust Act has concluded with respect to the sale of 100% of its equity...